An Analysis of Methylome Evolution in Primates. (27th June 2021)

• Record Type: Journal Article
• Authors: Sahm, Arne; Koch, Philipp; Horvath, Steve; Hoffmann, Steve
• Editors: Liu, Li
• Is Part Of: Molecular biology and evolution. Volume 38:Number 11(2021)
• Page Start: 4700
• Page End: 4714
• Publication Date: 2021-06-27
• Subjects: methylation -- human -- great apes -- epigenomics -- phylogenetics -- polycomb repressor 2; Molecular biology -- Periodicals; Molecular evolution -- Periodicals; Evolution, Molecular -- Periodicals; Molecular Biology -- Periodicals; 572.8
• DOI: 10.1093/molbev/msab189
• Languages: English
• ISSNs: 0737-4038

Abstract

Abstract: Although the investigation of the epigenome becomes increasingly important, still little is known about the long-term evolution of epigenetic marks and systematic investigation strategies are still lacking. Here, we systematically demonstrate the transfer of classic phylogenetic methods such as maximum likelihood based on substitution models, parsimony, and distance-based to interval-scaled epigenetic data. Using a great apes blood data set, we demonstrate that DNA methylation is evolutionarily conserved at the level of individual CpGs in promotors, enhancers, and genic regions. Our analysis also reveals that this epigenomic conservation is significantly correlated with its transcription factor binding density. Binding sites for transcription factors involved in neuron differentiation and components of AP-1 evolve at a significantly higher rate at methylation than at the nucleotide level. Moreover, our models suggest an accelerated epigenomic evolution at binding sites of BRCA1, chromobox homolog protein 2, and factors of the polycomb repressor 2 complex in humans. For most genomic regions, the methylation-based reconstruction of phylogenetic trees is at par with sequence-based reconstruction. Most strikingly, phylogenetic reconstruction using methylation rates in enhancer regions was ineffective independently of the chosen model. We identify a set of phylogenetically uninformative CpG sites enriched in enhancers controlling immune-related genes.